Nippon Shinyaku News and Activities
Presence
Nippon Shinyaku develops, manufactures, and sells pharmaceutical and healthcare products. Its main offerings include prescription medicines, medical nutrition products, and functional foods for hospitals, clinics, pharmacies, and consumers.
Nippon Shinyaku products and services overview:
- Prescription medicines
- Rare disease therapies
- Medical nutrition
- Functional foods
- Health supplements
- Diagnostic agents
Revenue: ~$1 billion
Employees: 5,974
Headquarters: Kyoto, Japan
Nippon Shinyaku is one of the...
Nippon Shinyaku is a company listed under the stock ticker 4516 (JP).
Executives
View the org chart displaying its 20 main executives
Most searched biographies at Nippon Shinyaku
- Shigenobu Maekawa, President, Representative Director
- Hitomi Kimura, Director
- Takanori Edamitsu, Director
Create your alert
to follow the executive moves at Nippon Shinyaku.
Pharmaceuticals
Nippon Shinyaku has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Nippon Shinyaku
Social media about Nippon Shinyaku
- Nippon Shinyaku on Wikipedia, Google News & Yahoo Finance
- Nippon Shinyaku on LinkedIn, X (Twitter) & YouTube
